$21.90
-0.31[-1.40%]
At close: Apr 26
$21.90
0[0.00%]
After Hours: 7:33PM EDT
Corcept Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Corcept Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/01/2024 | PM | CORT | Q1 | $0.14 | $0.23 | — | — | $105.65M | $140.80M | — | — | Get Alert |
02/15/2024 | PM | CORT | Q4 | $0.14 | $0.26 | $0.28 | 7.69% | $103.06M | $129.30M | $135.41M | 4.72% | Get Alert |
11/01/2023 | PM | CORT | Q3 | $0.30 | $0.21 | $0.28 | 33.33% | $101.73M | $119.34M | $123.60M | 3.57% | Get Alert |
08/02/2023 | PM | CORT | Q2 | $0.24 | $0.15 | $0.25 | 66.67% | $103.39M | $109.71M | $117.72M | 7.30% | Get Alert |
05/03/2023 | PM | CORT | Q1 | $0.20 | $0.19 | $0.14 | -26.32% | $93.70M | $104.87M | $105.65M | 0.75% | Get Alert |
02/28/2023 | PM | CORT | Q4 | $0.35 | $0.22 | $0.14 | -36.36% | $98.82M | $105.08M | $103.06M | -1.93% | Get Alert |
11/03/2022 | PM | CORT | Q3 | $0.30 | $0.22 | $0.30 | 36.36% | $96.13M | $107.59M | $101.73M | -5.45% | Get Alert |
08/03/2022 | PM | CORT | Q2 | $0.30 | $0.21 | $0.24 | 14.29% | $91.59M | $101.00M | $103.39M | 2.36% | Get Alert |
05/05/2022 | PM | CORT | Q1 | $0.20 | $0.24 | $0.20 | -16.67% | $79.44M | $98.88M | $93.70M | -5.24% | Get Alert |
02/15/2022 | PM | CORT | Q4 | $0.27 | $0.21 | $0.35 | 66.67% | $85.73M | $100.57M | $98.82M | -1.74% | Get Alert |
11/03/2021 | PM | CORT | Q3 | $0.24 | $0.20 | $0.30 | 50.00% | $86.33M | $97.19M | $96.13M | -1.09% | Get Alert |
07/29/2021 | PM | CORT | Q2 | $0.32 | $0.16 | $0.30 | 87.50% | $88.56M | $86.84M | $91.59M | 5.47% | Get Alert |
05/06/2021 | PM | CORT | Q1 | $0.34 | $0.21 | $0.20 | -4.76% | $93.25M | $91.81M | $79.44M | -13.48% | Get Alert |
02/23/2021 | PM | CORT | Q4 | $0.33 | $0.19 | $0.27 | 42.11% | $87.89M | $87.77M | $85.73M | -2.32% | Get Alert |
11/03/2020 | PM | CORT | Q3 | $0.31 | $0.20 | $0.24 | 20.00% | $81.50M | $90.87M | $86.33M | -5.00% | Get Alert |
08/04/2020 | PM | CORT | Q2 | $0.25 | $0.22 | $0.32 | 45.45% | $72.26M | $90.14M | $88.56M | -1.75% | Get Alert |
05/04/2020 | PM | CORT | Q1 | $0.20 | $0.22 | $0.34 | 54.55% | $64.83M | $87.01M | $93.25M | 7.17% | Get Alert |
02/20/2020 | PM | CORT | Q4 | $0.24 | $0.25 | $0.33 | 32.00% | $66.83M | $87.67M | $87.89M | 0.26% | Get Alert |
11/07/2019 | PM | CORT | Q3 | $0.22 | $0.20 | $0.31 | 55.00% | $64.44M | $78.00M | $81.50M | 4.49% | Get Alert |
Corcept Therapeutics (CORT) is scheduled to report earnings on May 1, 2024. The last reported earnings were for reported on February 15, 2024 for Q4.
The Actual EPS was $0.28, which beat the estimate of $0.26.
The Actual Revenue was $135.4M, which beat the estimate of $129.3M.
Browse earnings estimates, EPS, and revenue on all stocks.